Clinical Trials Logo

Clinical Trial Summary

The LINDA thermal device consists of a thermal camera attachable to a cell phone and an application for connection with an artificial intelligence program based on a convolutional neural network for classification of thermographic breast images. The system is previously fed with thermographic images of the breast and their respective results/diagnostics. The images are processed in an automated way and return a percentage of chance of having a pathological pattern.


Clinical Trial Description

The LINDA thermal device consists of a thermal camera attachable to a cell phone and an application for connection with an artificial intelligence program based on a convolutional neural network for classification of thermographic breast images. The system is previously fed with thermographic images of the breast and their respective results/diagnostics. The images are processed in an automated way and return a percentage of chance of having a pathological pattern. nfrared imaging (thermography) was approved as an auxiliary imaging modality for mammography by the Food and Drug Administration (FDA) in 1982. Thermography is a non-invasive, non-contact method without ionizing radiation, which is why its use can be prolonged and repeated. This technique allows for an evaluation of the functionality of the structures, which is why it is considered a physiological test and records the variation in the surface temperature of the human body based on the infrared radiation emitted by the surface of that body. It is capable of detecting tumor lesions since cancer cells generate heat due to the release of nitric oxide in the blood, causing changes in microcirculation, vasodilation, neo-angiogenesis and increased metabolic activity of cancer cells. Thus, in the initial stage of breast cancer, when it has not yet caused anatomical changes, there will be physiological changes that will lead to an increase in blood flow and metabolic activity. This increase induces a temperature rise in the area which will then be detected by thermography. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05009277
Study type Observational
Source Azidus Brasil
Contact Rubens F Mendrone
Phone +5511942576409
Email rubensfm@projetolinda.com.br
Status Recruiting
Phase
Start date August 30, 2021
Completion date January 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04983875 - Mammography and Breast Arterial Calcification: An Information-Sharing Trial N/A
Recruiting NCT04904757 - Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening N/A
Recruiting NCT05975736 - Searching for Masses and Calcifications at the Same Time in Breast Cancer Screening N/A
Withdrawn NCT03639129 - Improving Characterization of Calcifications With Contrast-Enhanced Mammography N/A
Completed NCT03684733 - Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
Completed NCT00827307 - Zoladex Plus Tamoxifen in Breast Cancer N/A
Completed NCT00724516 - Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography N/A
Completed NCT04009278 - Self-compression Mammography in Clinical Practice N/A
Completed NCT01124019 - Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography
Recruiting NCT03857152 - Can Contrast Enhanced Spectral Mammography (CESM) Reduce the Number of Benign Biopsies for Calcifications Without Negatively Impacting on Detection/Diagnosis of Clinically Significant Calcifications N/A
Recruiting NCT05199701 - Prospective Case Collection Study for New Mammography Technologies N/A
Completed NCT04741503 - Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool N/A
Not yet recruiting NCT06265207 - The Effect of Virtual Reality on Pain, Anxiety and Satisfaction Level Before Mammography N/A